Discussion - Preventing cardiovascular disease in patients with T2DM: how to apply novel outcome data with GLP-1 ra to clinical practice.
19 April 2018 (13:40 - 13:45)
Organised by:
Slides
About the speakers
University Medical Center Utrecht, Utrecht (Netherlands (The))
Oxford (United Kingdom of Great Britain & Northern Ireland)
Karolinska Institute, Stockholm (Sweden)
4 More presentations in this session
Professor R. Hobbs (Oxford, GB)
Professor D. Grobbee (Utrecht, NL)
Professor L. Ryden (Stockholm, SE)
Access the full session
The Event
EuroPrevent 2018
19 April 2018
13:40 CET
You may be interested in
Congress Presentation
Webinar
5 February 2020
Webinar
